Final Results From a Phase I Dose Escalation Study (DESTROY-1) in Stereotactic Boost After Prior Radiotherapy

Authors
Category Primary study
JournalClin. Oncol.
Year 2026
This article has no abstract
Epistemonikos ID: f2c34cb34d6670b015413fe4e2b32763f032ef7d
First added on: Oct 17, 2026